Rapid Dose Therapeutics Corp. reported earnings results for the third quarter and nine months ended November 30, 2021. For the third quarter, the company reported sales was CAD 0.457724 million compared to CAD 0.126471 million a year ago. Net loss was CAD 0.790751 million compared to CAD 0.511801 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 0.913562 million compared to CAD 0.130287 million a year ago. Net loss was CAD 1.19 million compared to CAD 1.45 million a year ago.